The tumor suppressor LATS2 reduces v-Src-induced membrane blebs in a kinase activity-independent manner

Masayoshi Ikeuchi1,2, Ryuzaburo Yuki1, Youhei Saito1

  • 1Department of Biochemistry & Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Insights

The oncogene v-Src suppresses LATS2 kinase activity, promoting cell cycle progression in tetraploid cells. Kinase-deficient LATS2, along with Merlin, maintains cortical rigidity at the plasma membrane, potentially suppressing tumors.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Tetraploid cells can drive cellular transformation through genetic diversity.
  • Large tumor suppressor 2 (LATS2) kinase normally suppresses tetraploid cell cycle progression by inhibiting YAP.
  • The oncogene v-Src was previously shown to induce tetraploidy and promote cell cycle progression by suppressing LATS2.

Purpose of the Study:

  • To elucidate the mechanism by which v-Src suppresses LATS2 activity.
  • To investigate the role of LATS2 in v-Src-expressing cells.

Main Methods:

  • Investigated direct phosphorylation of LATS2 by v-Src and c-Src.
  • Analyzed the localization and interaction of LATS2 and Merlin in v-Src-expressing cells.
  • Utilized knockdown and reexpression of LATS2 mutants to assess functional roles.

Main Results:

  • v-Src directly phosphorylates and inhibits LATS2 kinase activity.
  • Kinase-deficient LATS2 accumulates and interacts with Merlin at the plasma membrane.
  • LATS2 and Merlin cooperate at the plasma membrane to maintain cortical rigidity, suppressing bleb formation.

Conclusions:

  • v-Src-mediated suppression of LATS2 kinase activity is crucial for promoting cell cycle progression in tetraploid cells.
  • Kinase-deficient LATS2, in complex with Merlin, plays a novel role in maintaining plasma membrane integrity.
  • This interaction may represent a tumor suppressive mechanism in v-Src-expressing cells.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
16.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.8K